Furthermore, only minor differences in expression of activating and inhibitory NK cell receptors were noted, with the exception of an increased expression of NKG2D on NK cells from patients with NASH. This evidence concerns the gene KLRK1 and metabolic dysfunction-associated steatohepatitis.